Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity

Eleftheriadis,Theodoros; Pissas,Georgios; Mavropoulos,Athanasios; Liakopoulos,Vassilios; Stefanidis,Ioannis

doi:10.3892/br.2017.980

Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity

Authors:
- Theodoros Eleftheriadis
- Georgios Pissas
- Athanasios Mavropoulos
- Vassilios Liakopoulos
- Ioannis Stefanidis
View Affiliations

Affiliations: Department of Nephrology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece, Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece
Published online on: September 11, 2017 https://doi.org/10.3892/br.2017.980
Pages: 439-444

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cell metabolism is altered during T-cell and B-cell activation and differentiation. Clarifying the exact metabolic shifts may lead to the development of new immunosuppressive medications. In this study, the effect of the aerobic glycolysis inhibitor dichloroacetate (DCA) and of the Krebs cycle enzyme malate dehydrogenase 2 (MDH2) inhibitor LW6 on T-cell alloimmune clonal expansion and on alloantibody production, was evaluated. T-cell clonal expansion was assessed in two-way mixed lymphocyte reaction (MLR). Humoral alloimmunity was evaluated by the alloantibody production in one-way MLR. For this purpose, an antibody-mediated complement‑dependent cytotoxicity assay was developed in which the supernatants from one-way MLRs were used against resting peripheral blood mononuclear cells (PBMCs) derived from the same individual that contributed the stimulator cells for the respective MLR. DCA had a minimum effect on alloimmune T-cell clonal expansion, whereas it increased humoral immunity significantly. LW6 decreased both alloimmune T-cell proliferation and alloantibody production. The results indicate that MDH2 may be a perfect target for the development of new immunosuppressive medications, especially when inhibition of both cellular and humoral alloimmunity is desirable.

View Figures

View References

1	Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ and Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 341:1725–1730. 1999. View Article : Google Scholar : PubMed/NCBI
2	Hricik DE: Transplant immunology and immunosuppression: Core curriculum 2015. Am J Kidney Dis. 65:956–966. 2015. View Article : Google Scholar : PubMed/NCBI
3	Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG and Rathmell JC: Cutting edge: Distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4⁺ T cell subsets. J Immunol. 186:3299–3303. 2011. View Article : Google Scholar : PubMed/NCBI
4	Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, McCormick LL, Fitzgerald P, Chi H, Munger J, et al: The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 35:871–882. 2011. View Article : Google Scholar : PubMed/NCBI
5	Caro-Maldonado A, Gerriets VA and Rathmell JC: Matched and mismatched metabolic fuels in lymphocyte function. Semin Immunol. 24:405–413. 2012. View Article : Google Scholar : PubMed/NCBI
6	Roos D and Loos JA: Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Exp Cell Res. 77:127–135. 1973. View Article : Google Scholar : PubMed/NCBI
7	Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, OSullivan D, Huang SC, van der Windt GJ, Blagih J, Qiu J, et al: Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 153:1239–1251. 2013. View Article : Google Scholar : PubMed/NCBI
8	Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, Wang CR, Schumacker PT, Licht JD, Perlman H, et al: Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 38:225–236. 2013. View Article : Google Scholar : PubMed/NCBI
9	Yin Y, Choi SC, Xu Z, Zeumer L, Kanda N, Croker BP and Morel L: Glucose oxidation is critical for CD4⁺ T cell activation in a mouse model of systemic lupus erythematosus. J Immunol. 196:80–90. 2016. View Article : Google Scholar : PubMed/NCBI
10	Bental M and Deutsch C: Metabolic changes in activated T cells: An NMR study of human peripheral blood lymphocytes. Magn Reson Med. 29:317–326. 1993. View Article : Google Scholar : PubMed/NCBI
11	Matés JM, Segura JA, Martín-Rufián M, Campos-Sandoval JA, Alonso FJ and Márquez J: Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer. Curr Mol Med. 13:514–534. 2013. View Article : Google Scholar : PubMed/NCBI
12	Garcia-Manteiga JM, Mari S, Godejohann M, Spraul M, Napoli C, Cenci S, Musco G and Sitia R: Metabolomics of B to plasma cell differentiation. J Proteome Res. 10:4165–4176. 2011. View Article : Google Scholar : PubMed/NCBI
13	Dufort FJ, Gumina MR, Ta NL, Tao Y, Heyse SA, Scott DA, Richardson AD, Seyfried TN and Chiles TC: Glucose-dependent de novo lipogenesis in B lymphocytes: A requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J Biol Chem. 289:7011–7024. 2014. View Article : Google Scholar : PubMed/NCBI
14	Caro-Maldonado A, Wang R, Nichols AG, Kuraoka M, Milasta S, Sun LD, Gavin AL, Abel ED, Kelsoe G, Green DR, et al: Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol. 192:3626–3636. 2014. View Article : Google Scholar : PubMed/NCBI
15	Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, et al: Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15:110–121. 2012. View Article : Google Scholar : PubMed/NCBI
16	Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, et al: XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity. 21:81–93. 2004. View Article : Google Scholar : PubMed/NCBI
17	Lam WY, Becker AM, Kennerly KM, Wong R, Curtis JD, Llufrio EM, McCommis KS, Fahrmann J, Pizzato HA, Nunley RM, et al: Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells. Immunity. 45:60–73. 2016. View Article : Google Scholar : PubMed/NCBI
18	Crawford J and Cohen HJ: The essential role of L-glutamine in lymphocyte differentiation in vitro. J Cell Physiol. 124:275–282. 1985. View Article : Google Scholar : PubMed/NCBI
19	Stacpoole PW: The pharmacology of dichloroacetate. Metabolism. 38:1124–1144. 1989. View Article : Google Scholar : PubMed/NCBI
20	Eleftheriadis T, Sounidaki M, Pissas G, Antoniadi G, Liakopoulos V and Stefanidis I: In human alloreactive CD4+ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets. Mol Med Rep. 13:3370–3376. 2016. View Article : Google Scholar : PubMed/NCBI
21	Lee K, Ban HS, Naik R, Hong YS, Son S, Kim BK, Xia Y, Song KB, Lee HS and Won M: Identification of malate dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6 using chemical probes. Angew Chem Int Ed Engl. 52:10286–10289. 2013. View Article : Google Scholar : PubMed/NCBI
22	Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V and Stefanidis I: Malate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells. Exp Ther Med. 10:1959–1966. 2015. View Article : Google Scholar : PubMed/NCBI
23	Friedman B, Goodman EH Jr, Saunders HL, Kostos V and Weinhouse S: Estimation of pyruvate recycling during gluconeogenesis in perfused rat liver. Metabolism. 20:2–12. 1971. View Article : Google Scholar : PubMed/NCBI
24	Rümke HC, Terpstra FG, Huis B, Out TA and Zeijlemaker WP: Immunoglobulin production in human mixed lymphocyte cultures: Implications for co-cultures of cells from patients and healthy donors. J Immunol. 128:696–701. 1982.PubMed/NCBI
25	Konishi E, Kitai Y and Kondo T: Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: Application to nonstructural protein 1 in a model of Japanese encephalitis virus. Clin Vaccine Immunol. 15:88–94. 2008. View Article : Google Scholar : PubMed/NCBI
26	Eleftheriadis T, Pissas G, Sounidaki M, Antoniadi G, Antoniadis N, Liakopoulos V and Stefanidis I: In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity. Int Urol Nephrol. May 15–2017.(Epub ahead of print). View Article : Google Scholar
27	Sato T, Deiwick A, Raddatz G, Koyama K and Schlitt HJ: Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): Influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immunol. 115:301–308. 1999. View Article : Google Scholar : PubMed/NCBI
28	Ostroukhova M, Goplen N, Karim MZ, Michalec L, Guo L, Liang Q and Alam R: The role of low-level lactate production in airway inflammation in asthma. Am J Physiol Lung Cell Mol Physiol. 302:L300–L307. 2012. View Article : Google Scholar : PubMed/NCBI
29	Cai P, Boor PJ, Khan MF, Kaphalia BS, Ansari GA and Konig R: Immuno- and hepato-toxicity of dichloroacetic acid in MRL^+/+ and B₆C₃F₁ mice. J Immunotoxicol. 4:107–115. 2007. View Article : Google Scholar : PubMed/NCBI
30	Bian L, Josefsson E, Jonsson IM, Verdrengh M, Ohlsson C, Bokarewa M, Tarkowski A and Magnusson M: Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res Ther. 11:R1322009. View Article : Google Scholar : PubMed/NCBI
31	Ohashi T, Akazawa T, Aoki M, Kuze B, Mizuta K, Ito Y and Inoue N: Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity. Int J Cancer. 133:1107–1118. 2013. View Article : Google Scholar : PubMed/NCBI
32	Lelis FJN, Jaufmann J, Singh A, Fromm K, Teschner AC, Pöschel S, Schäfer I, Beer-Hammer S, Rieber N and Hartl D: Myeloid-derived suppressor cells modulate B-cell responses. Immunol Lett. 188:108–115. 2017. View Article : Google Scholar : PubMed/NCBI
33	Simioni PU, Fernandes LG and Tamashiro WM: Downregulation of L-arginine metabolism in dendritic cells induces tolerance to exogenous antigen. Int J Immunopathol Pharmacol. 30:44–57. 2017. View Article : Google Scholar : PubMed/NCBI
34	Bromage E, Stephens R and Hassoun L: The third dimension of ELISPOTs: Quantifying antibody secretion from individual plasma cells. J Immunol Methods. 346:75–79. 2009. View Article : Google Scholar : PubMed/NCBI
35	Aoyagi Y, Tasaki I, Okumura J and Muramatsu T: Energy cost of whole-body protein synthesis measured in vivo in chicks. Comp Biochem Physiol A Comp Physiol. 91:765–768. 1988. View Article : Google Scholar : PubMed/NCBI